Usefulness of adrenal scintigraphy in the follow-up of adrenocortical incidentalomas: A prospective multicenter study

European Journal of Endocrinology

Volumn 160, Issue 2, 2009, Pages 257-264

  Fagour, Cédric ^a   Bardet, Stéphane ^b   Rohmer, Vincent ^c   Arimone, Yannick ^d   Lecomte, Pierre ^e   Valli, Nathalie ^a   Tabarin, Antoine ^a  

^a HAUT LÉVÊQUE HOSPITAL   (France)

^b CENTRE FRANÇOIS BACLESSE   (France)

^c ANGERS UNIVERSITY HOSPITAL   (France)

^d UNIVERSITÉ DE BORDEAUX   (France)

^e UNIVERSITY HOSPITAL OF TOURS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

6BETA IODOMETHYL 19 NORCHOLEST 5(10) EN 3BETA OL I 131; CORTICOTROPIN; DEXAMETHASONE; HYDROCORTISONE; DIAGNOSTIC AGENT; RADIOACTIVE IODINE;

ADRENAL INCIDENTALOMA; ADRENAL SCINTISCANNING; ADULT; ARTICLE; CLINICAL TRIAL; CORTICOTROPIN BLOOD LEVEL; CUSHING SYNDROME; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DRUG UPTAKE; FEMALE; FOLLOW UP; HUMAN; HYDROCORTISONE URINE LEVEL; HYPERCORTISOLISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; TUMOR GROWTH; TUMOR VOLUME; ADENOMA; ADRENAL CORTEX TUMOR; AGED; INCIDENTAL FINDING; METHODOLOGY; MIDDLE AGED; NEOPLASM; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; RISK FACTOR; SCINTISCANNING;

ADENOMA; ADRENAL CORTEX NEOPLASMS; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENTAL FINDINGS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RADIONUCLIDE IMAGING; RISK FACTORS;

EID: 61449170141     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0299     Document Type: Article

References (43)

1. Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Ali A, Giovagnetti M, Opocher G & Angeli A. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. Journal of Clinical Endocrinology and Metabolism 2000 85 637-644.
2. Mansmann G, Lau J, Balk E, Rothberg M, Miyachi Y & Bornstein SR. The clinically inapparent adrenal mass: update in diagnosis and management. Endocrine Reviews 2004 25 309-340.
3. Grumbach MM, Biller BM, Braunstein GD, Campbell KK, Carney JA, Godley PA, Harris EL, Lee JK, Oertel YC, Posner MC, Schlechte JA & Wieand HS. Management of the clinically inapparent adrenal mass ('incidentaloma'). Annals of Internal Medicine 2003 138 424-429.
4. Terzolo M, Bovio S, Reimondo G, Pia A, Osella G, Borretta G & Angeli A. Subclinical Cushing's syndrome in adrenal incidentalomas. Endocrinology and Metabolism Clinics of North America 2005 34 423-439 (x).
5. Beierwaltes WH, Sturman MF, Ryo U & Ice RD. Imaging functional nodules of the adrenal glands with 131-I-19-iodocholesterol. Journal of Nuclear Medicine 1974 15 246-251.
6. Charbonnel B, Chatal JF & Ozanne P. Does the corticoadrenal adenoma with 'pre-Cushing's syndrome' exist? Journal of Nuclear Medicine 1981 22 1059-1061.
7. 131I-6 Beta- iodomethylnorcholesterol scintigraphy: an assessment of its role in the investigation of adrenocortical incidentalomas. Clinical Endocrinology 1996 44 587-596.
8. Valli N, Catargi B, Ronci N, Vergnot V, Leccia F, Ferriere JM, Chene G, Grenier N, Laurent F & Tabarin A. Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas. European Journal of Endocrinology 2001 144 401-408.
9. Barzon L, Scaroni C, Sonino N, Fallo F, Gregianin M, Macri C & Boscaro M. Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates. Journal of Clinical Endocrinology and Metabolism 1998 83 55-62.
10. Imperiale A, Olianti C, Mannelli M, La Cava G & Pupi A. Tomographic evaluation of [131I] 6beta-iodomethyl-norcholesterol standardised uptake trend in clinically silent monolateral and bilateral adrenocortical incidentalomas. Quarterly Journal of Nuclear Medicine and Molecular Imaging 2005 49 287-296.
11. Bulow B, Jansson S, Juhlin C, Steen L, Thoren M, Wahrenberg H, Valdemarsson S, Wangberg B & Ahreen B. Adrenal incidentaloma - follow-up results from a Swedish prospective study. European Journal of Endocrinology 2006 154 419-423.
12. Bernini GP, Moretti A, Oriandini C, Bardini M, Taurino C & Salvetti A. Long-term morphological and hormonal follow-up in a single unit on 115 patients with adrenal incidentalomas. British Journal of Cancer 2005 92 1104-1109.
13. Barzon L, Fallo F, Sonino N & Boscaro M. Development of overt Cushing's syndrome in patients with adrenal incidentaloma. European Journal of Endocrinology 2002 146 61-66.
14. Barzon L, Scaroni C, Sonino N, Fallo F, Paoletta A & Boscaro M. Risk factors and long-term follow-up of adrenal incidentalomas. Journal of Clinical Endocrinology and Metabolism 1999 84 520-526.
15. Barzon L, Sonino N, Fallo F, Palu G & Boscaro M. Prevalence and natural history of adrenal incidentalomas. European Journal of Endocrinology 2003 149 273-285.
16. Libe R, Dall'asta C, Barbetta L, Baccarelli A, Beck-Peccoz P & Ambrosi B. Long-term follow-up study of patients with adrenal incidentalomas. European Journal of Endocrinology 2002 147 489-494.
17. Caoili EM, Korobkin M, Francis IR, Cohan RH, Platt JF, Dunnick NR & Raghupathi KI. Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology 2002 222 629-633.
18. Tsagarakis S, Kokkoris P, Roboti C, Malagari C, Kaskarelis J, Vlassopoulou V, Alevizaki C & Thalassinos N. The low-dose dexamethasone suppression test in patients with adrenal incidentalomas: comparisons with clinically euadrenal subjects and patients with Cushing's syndrome. Clinical Endocrinology 1998 48 627-633.
19. Tsagarakis S, Roboti C, Kokkoris P, Vasiliou V, Alevizaki C & Thalassinos N. Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary-adrenal axis in patients with adrenal incidentalomas. Clinical Endocrinology 1998 49 165-171.
20. Huizenga NA, Koper JW, De Lange P, Pols HA, Stolk RP, Grobbee DE, De Jong FH & Lamberts SW. Interperson variability but intraperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo- pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals. Journal of Clinical Endocrinology and Metabolism 1998 83 47-54.
21. Findling JW, Raff H & Aron DC. The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 2004 89 1222-1226.
22. Terzolo M, Osella G, Ali A, Borretta G, Cesario F, Paccotti P & Angeli A. Subclinical Cushing's syndrome in adrenal incidentaloma. Clinical Endocrinology 1998 48 89-97.
23. Rossi R, Tauchmanova L, Luciano A, Di Martino M, Battista C, Del Viscovo L, Nuzzo V & Lombardi G. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. Journal of Clinical Endocrinology and Metabolism 2000 85 1440-1448.
24. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM & Montori VM. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism 2008 93 1526-1540.
25. Catargi B, Rigalleau V, Poussin A, Ronci-Chaix N, Bex V, Vergnot V, Gin H, Roger P & Tabarin A. Occult Cushing's syndrome in type-2 diabetes. Journal of Clinical Endocrinology and Metabolism 2003 88 5808-5813.
26. Chiodini I, Torlontano M, Scillitani A, Arosio M, Bacci S, Di Lembo S, Epaminonda P, Augello G, Enrini R, Ambrosi B, Adda G & Trischitta V. Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients. European Journal of Endocrinology 2005 153 837-844.
27. Chiodini I, Mascia ML, Muscarella S, Battista C, Minisola S, Arosio M, Santini SA, Guglielmi G, Carnevale V & Scillitani A. Subclinical hypercortisolism among outpatients referred for osteoporosis. Annals of Internal Medicine 2007 147 541-548.
28. Findling JW & Raff H. Screening and diagnosis of Cushing's syndrome. Endocrinology and Metabolism Clinics of North America 2005 34 385-402 (ix-x).
29. Kidambi S, Raff H & Findling JW. Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing's syndrome. European Journal of Endocrinology 2007 157 725-731.
30. Grossrubatscher E, Vignati F, Possa M & Lohi P. The natural history of incidentally discovered adrenocortical adenomas: a retrospective evaluation. Journal of Endocrinological Investigation 2001 24 846-855.
31. Boscaro M, Barzon L, Fallo F & Sonino N. Cushing's syndrome. Lancet 2001 357 783-791.
32. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman LK, Sonino N, Vance ML, Giustina A & Boscaro M. Diagnosis and complications of Cushing's syndrome: a consensus statement. Journal of Clinical Endocrinology and Metabolism 2003 88 5593-5602.
33. Meinardi JR, Wolffenbuttel BH & Dullaart RP. Cyclic Cushing's syndrome: a clinical challenge. European Journal of Endocrinology 2007 157 245-254.
34. Radiation dose to patients from radiopharmaceuticals (addendum 2 to ICRP publication 53). Annals of the ICRP 1998 28 1-126.
35. Dwamena BA, Kloos RT, Fendrick AM, Gross MD, Francis IR, Korobkin MT & Shapiro B. Diagnostic evaluation of the adrenal incidentaloma: decision and cost-effectiveness analyses. Journal of Nuclear Medicine 1998 39 707-712.
36. Reincke M, Nieke J, Krestin GP, Saeger W, Allolio B & Winkelmann W. Preclinical Cushing's syndrome in adrenal 'incidentalomas': comparison with adrenal Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 1992 75 826-832.
37. Angeli A & Terzolo M. Adrenal incidentaloma - a modern disease with old complications. Journal of Clinical Endocrinology and Metabolism 2002 87 4869-4871.
38. Terzolo M, Pia A, Ali A, Osella G, Reimondo G, Bovio S, Daffara F, Procopio M, Paccotti P, Borretta G & Angeli A. Adrenal incidentaloma: a new cause of the metabolic syndrome? Journal of Clinical Endocrinology and Metabolism 2002 87 998-1003.
39. Tauchmanova L, Rossi R, Biondi B, Pulcrano M, Nuzzo V, Palmieri EA, Fazio S & Lombardi G. Patients with subclinical Cushing's syndrome due to adrenal adenoma have increased cardiovascular risk. Journal of Clinical Endocrinology and Metabolism 2002 87 4872-4878.
40. Bernini G, Moretti A, Iacconi P, Miccoli P, Nami R, Lucani B & Salvetti A. Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery. European Journal of Endocrinology 2003 148 213-219.
41. Erbil Y, Ademoglu E, Ozbey N, Barbaros U, Yanik BT, Salmaslioglu A, Bozbora A & Ozarmagan S. Evaluation of the cardiovascular risk in patients with subclinical Cushing syndrome before and after surgery. World Journal of Surgery 2006 30 1665-1671.
42. Huizenga NA, Koper JW, De Lange P, Pols HA, Stolk RP, Burger H, Grobbee DE, Brinkmann AO, De Jong FH & Lamberts SW. A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. Journal of Clinical Endocrinology and Metabolism 1998 83 144-151.
43. Mitchell IC, Auchus RJ, Juneja K, Chang AY, Holt SA, Snyder WH III & Nwariaku FE. 'Subclinical Cushing's syndrome' is not subclinical: improvement after adrenalectomy in 9 patients. Surgery 2007 142 900-905.